Two states may soon join Texas in a multi-jurisdictional public-private partnership to develop a novel treatment for opioid addiction and other debilitating neurological conditions. House Bill 314 in Mississippi and House Bill 4626 in West Virginia both authorize their state health departments to administer a grant to an applicant that will conduct clinical trials of ibogaine according to protocols that must be approved by the ...